益生菌制剂联合美沙拉嗪治疗溃疡性结肠炎的疗效观察

被引:16
作者
周祥军
机构
[1] 丹阳市人民医院消化内科
关键词
溃疡性结肠炎; 益生菌制剂; 美沙拉嗪;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:354 / 356
页数:3
相关论文
共 5 条
[1]
Probiotics in inflammatory bowel disease: possible mechanisms of action [J].
Dotan, I ;
Rachmilewitz, D .
CURRENT OPINION IN GASTROENTEROLOGY, 2005, 21 (04) :426-430
[2]
Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients [J].
Naser, SA ;
Schwartz, D ;
Shafran, I .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (04) :1094-1095
[3]
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:: a randomised trial [J].
Rembacken, BJ ;
Snelling, AM ;
Hawkey, PM ;
Chalmers, DM ;
Axon, ATR .
LANCET, 1999, 354 (9179) :635-639
[4]
Antibiotics and probiotics in treatment of inflammatory bowel disease [J].
Gionchetti, Paolo ;
Rizzello, Fernando ;
Lammers, Karen M. ;
Morselli, Claudia ;
Sollazzi, Lucia ;
Davies, Samuel ;
Tambasco, Rosy ;
Calabrese, Carlo ;
Campieri, Massimo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (21) :3306-3313
[5]
亚太地区炎症性肠病处理共识意见(一) [J].
欧阳钦 ;
Rakesh Tandon ;
KL Goh ;
潘国宗 ;
KM Fock ;
Claudio Fiocchi ;
SK Lam ;
萧树东 ;
张虎 ;
梁红亮 ;
王玉芳 .
胃肠病学, 2006, (04) :233-238